Hines RN - Search Results

1

CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians.

Rettie AE, Tai G, Veenstra DL, Farin FM, Srinouanprachan S, Lin YS, Thummel KE, Hines RN. Rettie AE, et al. Among authors: hines rn. Blood. 2003 Apr 1;101(7):2896-7. doi: 10.1182/blood-2002-11-3452. Blood. 2003. PMID: 12642346 Free article. No abstract available.

2

Developmental expression of human hepatic CYP2C9 and CYP2C19.

Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN. Koukouritaki SB, et al. Among authors: hines rn. J Pharmacol Exp Ther. 2004 Mar;308(3):965-74. doi: 10.1124/jpet.103.060137. Epub 2003 Nov 21. J Pharmacol Exp Ther. 2004. PMID: 14634042

3

Novel CYP2C9 promoter variants and assessment of their impact on gene expression.

Kramer MA, Rettie AE, Rieder MJ, Cabacungan ET, Hines RN. Kramer MA, et al. Among authors: hines rn. Mol Pharmacol. 2008 Jun;73(6):1751-60. doi: 10.1124/mol.107.044149. Epub 2008 Feb 29. Mol Pharmacol. 2008. PMID: 18310303 Free PMC article.

4

Genotyping and site-directed mutagenesis of a cytochrome P450 meander Pro-X-Arg motif critical to CYP4B1 catalysis.

Zheng YM, Henne KR, Charmley P, Kim RB, McCarver DG, Cabacungan ET, Hines RN, Rettie AE. Zheng YM, et al. Among authors: hines rn. Toxicol Appl Pharmacol. 2003 Jan 15;186(2):119-26. doi: 10.1016/s0041-008x(02)00028-5. Toxicol Appl Pharmacol. 2003. PMID: 12639503

5

Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression.

Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, Hines RN. Koukouritaki SB, et al. Among authors: hines rn. Pediatr Res. 2002 Feb;51(2):236-43. doi: 10.1203/00006450-200202000-00018. Pediatr Res. 2002. PMID: 11809920

6

Developmental expression of the major human hepatic CYP3A enzymes.

Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, Zaya MJ. Stevens JC, et al. Among authors: hines rn. J Pharmacol Exp Ther. 2003 Nov;307(2):573-82. doi: 10.1124/jpet.103.054841. Epub 2003 Sep 15. J Pharmacol Exp Ther. 2003. PMID: 12975492

7

Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver.

Duanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, Kocarek TA, Runge-Morris M. Duanmu Z, et al. Among authors: hines rn. J Pharmacol Exp Ther. 2006 Mar;316(3):1310-7. doi: 10.1124/jpet.105.093633. Epub 2005 Dec 9. J Pharmacol Exp Ther. 2006. PMID: 16339912

8

Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants.

Koukouritaki SB, Poch MT, Henderson MC, Siddens LK, Krueger SK, VanDyke JE, Williams DE, Pajewski NM, Wang T, Hines RN. Koukouritaki SB, et al. Among authors: hines rn. J Pharmacol Exp Ther. 2007 Jan;320(1):266-73. doi: 10.1124/jpet.106.112268. Epub 2006 Oct 18. J Pharmacol Exp Ther. 2007. PMID: 17050781

9

Regulatory polymorphisms and their contribution to interindividual differences in the expression of enzymes influencing drug and toxicant disposition.

Hines RN, Koukouritaki SB, Poch MT, Stephens MC. Hines RN, et al. Drug Metab Rev. 2008;40(2):263-301. doi: 10.1080/03602530801952682. Drug Metab Rev. 2008. PMID: 18464046 Review.

10

Developmental changes in human liver CYP2D6 expression.

Stevens JC, Marsh SA, Zaya MJ, Regina KJ, Divakaran K, Le M, Hines RN. Stevens JC, et al. Among authors: hines rn. Drug Metab Dispos. 2008 Aug;36(8):1587-93. doi: 10.1124/dmd.108.021873. Epub 2008 May 12. Drug Metab Dispos. 2008. PMID: 18474679

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page